ciprofloxacin has been researched along with Acute Coronary Syndrome in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Navarro-Navajas, A | 1 |
| Casallas, I | 1 |
| Isaza, D | 1 |
| Ortiz, P | 1 |
| Baracaldo-Santamaría, D | 1 |
| Calderon-Ospina, CA | 1 |
1 other study available for ciprofloxacin and Acute Coronary Syndrome
| Article | Year |
|---|---|
Type III Kounis Syndrome Secondary to Ciprofloxacin-Induced Hypersensitivity.
Topics: Acute Coronary Syndrome; Aged; Ciprofloxacin; Humans; Hypersensitivity; Kounis Syndrome; Myocardial | 2022 |